G
Lab staff at work in a pharmaceutical laboratory. Image credit: iStock/Thinkstock.

What can investors learn about Johnson & Johnson (NYSE:JNJ) from its balance sheet? The slideshow below provides an answer, walking viewers through a simplified analysis of the pharma giant's assets, liabilities, and owner's equity.

The slideshow delves specifically into Johnson & Johnson's size, liquidity, and solvency, as well as the most popular methods used to measure these traits. And unlike an analysis of Johnson & Johnson's balance sheet itself, scrolling through the slideshow is designed to be an easy and enjoyable experience.


Slideshow data sourced from YCharts.com on Dec. 10, 2015. Image credits: iStock/Thinkstock.

John Maxfield has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.